Exicure (XCUR) Free Cash Flow (2016 - 2026)
Exicure (XCUR) reported Free Cash Flow of -$1.1 million for Q1 2026, up 28.54% on a YoY basis from -$888469.3 in Q1 2025, and down 22.27% quarter-over-quarter from -$934000.0 in Q4 2025.
Exicure (XCUR) Free Cash Flow (2016 - 2026) Analysis & Trends
Exicure has reported Free Cash Flow for 11 years, with the latest figure at -$1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 28.54% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (down 91.72% YoY), and the FY2025 full-year result was -$8.6 million, down 194.02% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.1 million, down from -$934000.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$449000.0 in Q3 2024, with the low at -$12.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$3.4 million across 5 years, with a median of -$1.6 million in 2025.
- Annual changes were most pronounced in 2023 — Free Cash Flow surged 88.79% — and 2025, when it tumbled 662.14%.
- Exicure's Free Cash Flow stood at -$7.3 million in 2022, then surged by 88.79% to -$816000.0 in 2023, then dropped by 3.55% to -$845000.0 in 2024, then fell by 10.53% to -$934000.0 in 2025, then fell by 22.27% to -$1.1 million in 2026.
- The last three Free Cash Flow figures came in at -$1.1 million (Q1 2026), -$934000.0 (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 63,220.27 |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | -1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -934,000.00 |
| Dec 31, 2025 | -934,000.00 |
| Sep 30, 2025 | -3.42 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -845,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Sep 30, 2024 | -449,000.00 |
| Sep 30, 2024 | -449,000.00 |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -450,000.00 |
| Mar 31, 2024 | -450,000.00 |
| Dec 31, 2023 | -816,000.00 |
| Dec 31, 2023 | -816,000.00 |